Company: MBIO
Filing Date: 2025-03-03
Form Type: DEF 14C
Source: 0001104659-25-019831
Chunk: 3

Company: MUSTANG BIO, INC.
Filing Date: 2025-03-03
Form: DEF 14C
Chunk 3
---
 cost of furnishing
this Information Statement will be borne by the Company. We will request brokerage houses, nominees, custodians, fiduciaries and other
like parties to forward this Information Statement to the beneficial owners of the common stock held of record by them and will reimburse
such persons for their reasonable charges and expenses in connection therewith.

<div align='center'>THE ATTACHED MATERIAL IS FOR INFORMATIONAL PURPOSES ONLY.

NO VOTE OR OTHER CONSENT OF OUR STOCKHOLDERS IS SOLICITED IN CONNECTION WITH THIS INFORMATION STATEMENT. WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND US A PROXY.

FORWARD-LOOKING INFORMATION</div>

This Information Statement
and other reports that we file with the Securities and Exchange Commission (the “SEC”) contain forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the
Exchange Act, which are often indicated by terms such as “anticipate,” “believe,” “could,” “estimate,”
“expect,” “goal,” “intend,” “look forward to,” “may,” “plan,”
“potential,” “predict,” “project,” “should,” “will,” “would” and
similar terms, variations of such terms or the negative of such terms. These statements are only predictions and involve known and unknown
risks, uncertainties and other factors, including those risks discussed elsewhere herein. All forward-looking statements included in this
document are based on information available to us on the date hereof, and we assume no obligation to update any such forward-looking statements.
Our business and financial performance are subject to substantial risks and uncertainties. Actual results could differ materially from
those projected in the forward-looking statements.

<div align='center'>RECORD DATE AND VOTE REQUIRED</div>

The close of business on February
19, 2025 has been fixed as the Record Date. As of February 19, 2025, we had (i) 1,910,131 shares of our common stock outstanding and entitled
to vote, (ii) 845,385 shares of our Class A common stock, par value $0.0001 per share (“Class A Common Stock”), outstanding
and entitled to vote, and (iii) 250,000 shares of our Class A Preferred Stock outstanding and entitled to vote. Each share of common stock
and Class A